Brain Tumor Reports

Volume 11 Number 11
November 2009

Home > Publications > Brain Tumor Reports > Volume 11, Year 2009 > Number 11, November°



Pekmezovic T, Golubicic I, Grujicic D, Tepavcevic DK, Jarebinski M, Radosavljevic A, Nikitovic M, Bogicevic S
Incidence of primary central nervous system tumors among children in Belgrade (Serbia), 1991-2004
Pediatr Hematol Oncol. 2009 Jul-Aug;26(5):332-7

Etiology & Pathogenesis

Bruzzone MG, Eoli M, Cuccarini V, Grisoli M, Valletta L, Finocchiaro G.
Genetic signature of adult gliomas and correlation with MRI features
Expert Rev Mol Diagn. 2009 Oct;9(7):709-20

Nobusawa S, Watanabe T, Kleihues P, Ohgaki H
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas
Clin Cancer Res. 2009 Oct 1;15(19):6002-7. Epub 2009 Sep 15

Overall Management

Han SJ, Yang I, Otero JJ, Ahn BJ, Tihan T, McDermott MW, Berger MS, Chang SM, Parsa AT.
Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients
J Neurosurg. 2010 May;112(5):990-6. Epub 2009 Oct 9


Felsberg J, Rapp M, Loeser S, Fimmers R, Stummer W, Goeppert M, Steiger HJ, Friedensdorf B, Reifenberger G, Sabel MC
Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients
Clin Cancer Res. 2009 Nov 1;15(21):6683-93. Epub 2009 Oct 27

Waki F, Ando M, Takashima A, Yonemori K, Nokihara H, Miyake M, Tateishi U, Tsuta K, Shimada Y, Fujiwara Y, Tamura T
Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors
J Neurooncol. 2009 Jun;93(2):205-12. Epub 2008 Nov 29
  Abstract |   Full Text |   Reprint

Psychosocial Aspects

Aarsen FK, Paquier PF, Arts WF, Van Veelen ML, Michiels E, Lequin M, Catsman-Berrevoets CE
Cognitive deficits and predictors 3 years after diagnosis of a pilocytic astrocytoma in childhood
J Clin Oncol. 2009 Jul 20;27(21):3526-32. Epub 2009 May 11

Poggi G, Liscio M, Pastore V, Adduci A, Galbiati S, Spreafico F, Gandola L, Massimino M.
Psychological intervention in young brain tumor survivors: the efficacy of the cognitive behavioural approach
Disabil Rehabil. 2009;31(13):1066-73

Stem Cells

Charles N, Holland EC.
Brain tumor treatment increases the number of cancer stem-like cells
Expert Rev Neurother. 2009 Oct;9(10):1447-9
Abstract |   Reprint |   Related articles

Ernst A, Hofmann S, Ahmadi R, Becker N, Korshunov A, Engel F, Hartmann C, Felsberg J, Sabel M, Peterziel H, Durchdewald M, Hess J, Barbus S, Campos B, Starzinski-Powitz A, Unterberg A, Reifenberger G, Lichter P, Herold-Mende C, Radlwimmer B
Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival
Clin Cancer Res. 2009 Nov 1;15(21):6541-50. Epub 2009 Oct 27

Piccirillo SG, Binda E, Fiocco R, Vescovi AL, Shah K
Brain cancer stem cells
J Mol Med. 2009 Nov;87(11):1087-95. Epub 2009 Sep 29
  Abstract |   Full text |   Reprint

Xie Z
Brain Tumor Stem Cells
Neurochem Res. 2009 Oct 24. [Epub ahead of print]


Clinical Investigations

Brandsma D, van den Bent MJ
Pseudoprogression and pseudoresponse in the treatment of gliomas
Curr Opin Neurol. 2009 Sep 16;. [Epub ahead of print]

Chaichana K, Parker S, Olivi A, Quiñones-Hinojosa A
A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme
J Neurosurg. 2009 Oct 9;. [Epub ahead of print]

Iwamoto FM, Abrey LE, Beal K, Gutin PH, Rosenblum MK, Reuter VE, DeAngelis LM, Lassman AB
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.
Neurology. 2009 Oct 13;73(15):1200-6
  Abstract |   Reprint |   Related articles

Roldán GB, Scott JN, McIntyre JB, Dharmawardene M, de Robles PA, Magliocco AM, Yan ES, Parney IF, Forsyth PA, Cairncross JG, Hamilton MG, Easaw JC.
Population-based study of pseudoprogression after chemoradiotherapy in GBM
Can J Neurol Sci. 2009 Sep;36(5):617-22

Zustovich F, Lombardi G, Della Puppa A, Rotilio A, Scienza R, Pastorelli D
A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma
Anticancer Res. 2009 Oct;29(10):4275-9